Home > Inhibitors & Agonists > Antibiotics and Antivirals
Cat. No. Product name CAS No.
DC11768 TAM-16

A benzofuran class inhibitor of M. tuberculosis Pks13 (Polyketide Synthase 13).

2030241-59-7
DC11531 Teslexivir

A first-in-class, small molecule protein-protein inhibitor of the interaction between the E1 and E2 proteins of HPV types 6 and 11.

1075798-37-6
DC12012 PD 404182

A heterocyclic iminobenzothiazine derivative with antimicrobial and anti-inflammatory properties, a potent inhibitor of human DDAH1 activity (IC50=9 uM) and elevates cellular ADMA levels.

72596-74-8
DC11823 BMS-929075

A highly potent, selective, orally bioavailable HCV NS5B polymerase inhibitor with IC50 of 9, 4, and 18 nM for GT1a, GT1b, and GT1b-C316N mutant in HCV replicon assay, respectively.

1217338-97-0
DC11892 Elsulfavirine

A new-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV-1 infections, the prodrug of the active compound VM-1500A..

868046-19-9
DC11998 IND-114338

A novel antiprion compound with EC50 of 68 nM, significantly increases monoglycosylated/diglycosylated PrPSc..

1426259-35-9
DC11534 Sudoterb

A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL..

676266-31-2
DC11535 Sudoterb dihydrchloride

A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL..

1044503-04-9
DC11997 IND125

A novel brain penetrant antiprion compound with EC50 of 57 nM, prevents both PrP(Sc) accumulation and astrocytic gliosis in the cerebrum.

DC11628 HIV-1 Integrase Inhibitor 1

A novel compound that disrupts the HIV-1 integrase LEDGF interaction.

2146094-22-4
DC11811 SCY-078

A novel orally bioavailable fungal beta-1,3-D glucan synthetase inhibitor against Candida species C. glabrata (MIC 0.03 to 0.25 ug/ml), C. parapsilosis (MIC 0.06 to 0.25 ug/ml).

1207753-03-4
DC11854 IDX899

A novel potent, selective HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) with EC50 of 1, 1.3, 2.8 and 11 nM for WT, K103N, Y181C and K103N/Y181C, respectively.

1018450-26-4
DC11527 Quilseconazole

A novel selective, orally available fungal CYP51 (lanosterol 14-α-demethylase) inhibitor.

1340593-70-5
DC11877 F3406

A novel small-molecule arenaviruse inhibitor that exhibits strong anti-LCMV activity (IC50<1 uM) without cell toxicity.

1115899-15-4
DC11825 MK-8876

A novel, broadly acting non-nucleoside inhibitor of HCV NS5B polymerase with IC50 of 3 nM and 2 nM for GT1b and GT2a, respectively.

1426960-33-9
DC11807 HIV InSTI-1

A potent HIV integrase strand transfer inhibitor (InSTIs) with IC50 of 8 nM in HIV replication assay.

1549802-58-5
DC11806 MK-0536

A potent HIV-1 integrase strand transfer inhibitor with IC50 of 33 nM, 9.5 nM, 40 nM, 20 nM and 237 nM for wt IN, IN Y143R, IN N155H, G118R and IN G140S-Q148H, respectively.

865298-81-3
DC11771 AZ-27

A potent non-nucleoside RSV L-protein polymerase inhibitor with EC50 of 0.01 uM and 1.3 uM for RSV A2 and RSV B-WST, respectively.

1516772-44-3
DC11773 BI Compound D

A potent non-nucleoside RSV L-protein polymerase inhibitor with IC50 of 89 nM.

851658-10-1
DC11772 AZD-4316

A potent respiratory syncytial virus (RSV) fusion inhibitor..

1243324-08-4
DC11647 JNJ-2408068

A potent RSV fusion inhibitor with EC50 of 0.16 nM against some lab strains.

317846-22-3
DC11731 Ruzasvir

A potent, pan-genotype HCV NS5A inhibitor with replicon EC90 of 0.003, 0.016, 0.067, 0.036, 0.007, and 0.007 nM for GT1a, GT1a L31V, GT1a Y93H, GT2b, GT3a, and Gt4a, respectively..

1613081-64-3
Page 1 / Total 9 FirstPrevNextLastGoto